[Ovid] Circulating Epstein每Barr virus DNA as a precision biomarker in nasopharyngeal carcinoma: from risk stratification to real-time treatment adaptation and disease surveillance |
|
This post will be closed automatically in 2026-10-05 02:25
Reward10points
|
10
639: HOSPITAL RESOURCE UTILIZATION IN THE PEERLESS RANDOMIZED CONTROLLED TRIAL FOR PULMONARY EMBOLISM
30
Predictive factors for visual acuity and metamorphopsia after epiretinal membrane surgery
10
Evidence-Based Performance Measures for Rhinoplasty: A Multidisciplinary Performance Measure Set
10
Behavior of blood vessels during lower-leg lengthening using the Ilizarov method.
10
Higher Neutrophil-to-Lymphocyte Ratio Is Associated With Better Response to Esketamine in Treatment-Resistant Depression
